Instituto Rosenbusch (BUE:ROSE) Cyclically Adjusted FCF per Share: ARS3.74 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BUE:ROSE Instituto Rosenbusch SA BUE:ROSE
37 GF Score
Price ARS156.00
GF Value ARS62.32
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Instituto Rosenbusch Cyclically Adjusted FCF per Share?

Instituto Rosenbusch BUE:ROSE -2.50% 37 Cyclically Adjusted FCF per Share is ARS3.74 as of Dec. 2025. GuruFocus rates BUE:ROSE with a GF Score™ of 37/100 and a GF Value™ of ARS62.32 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Instituto Rosenbusch's adjusted free cash flow per share for the three months ended in Dec. 2025 was ARS18.941. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ARS3.74 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Instituto Rosenbusch's average Cyclically Adjusted FCF Growth Rate was 40.60% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 116.20% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 140.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Instituto Rosenbusch was 165.00% per year. The lowest was 116.20% per year. And the median was 150.10% per year.

As of today (2026-07-23), Instituto Rosenbusch's current stock price is ARS156.00. Instituto Rosenbusch's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2025 was ARS3.74. Instituto Rosenbusch's Cyclically Adjusted Price-to-FCF of today is 41.71.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Instituto Rosenbusch was 270.00. The lowest was 19.00. And the median was 44.32.


Instituto Rosenbusch  (BUE:ROSE) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Instituto Rosenbusch's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=156.00/3.74
=41.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Instituto Rosenbusch was 270.00. The lowest was 19.00. And the median was 44.32.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Instituto Rosenbusch Cyclically Adjusted FCF per Share Related Terms


Instituto Rosenbusch Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Instituto Rosenbusch's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Instituto Rosenbusch Cyclically Adjusted FCF per Share Chart

Instituto Rosenbusch Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.37 0.93 2.66 3.74

Instituto Rosenbusch Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.66 3.96 1.95 1.78 3.74

BUE:ROSE vs ZTS, UTHR, VTRS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Instituto Rosenbusch's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Instituto Rosenbusch Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instituto Rosenbusch's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Instituto Rosenbusch's Cyclically Adjusted Price-to-FCF falls into.


BUE:ROSE
37GF Score
Instituto Rosenbusch SA BUE:ROSE
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Instituto Rosenbusch Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Instituto Rosenbusch's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=18.941/324.0540*324.0540
=18.941

Current CPI (Dec. 2025) = 324.0540.

Instituto Rosenbusch Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201603 -0.043 238.132 -0.059
201606 0.035 241.018 0.047
201609 -0.097 241.428 -0.130
201612 0.107 241.432 0.144
201703 -0.020 243.801 -0.027
201706 -0.108 244.955 -0.143
201709 -0.288 246.819 -0.378
201712 0.262 246.524 0.344
201803 -0.049 249.554 -0.064
201806 -0.536 251.989 -0.689
201809 -0.266 252.439 -0.341
201812 0.000 251.233 0.000
201903 0.490 254.202 0.625
201906 0.021 256.143 0.027
201909 0.242 256.759 0.305
201912 -0.367 256.974 -0.463
202003 -0.028 258.115 -0.035
202006 0.790 257.797 0.993
202009 -0.048 260.280 -0.060
202012 0.761 260.474 0.947
202103 -0.091 264.877 -0.111
202106 0.901 271.696 1.075
202109 0.140 274.310 0.165
202112 0.322 278.802 0.374
202203 1.967 287.504 2.217
202206 0.977 296.311 1.068
202209 -1.098 296.808 -1.199
202212 -0.186 296.797 -0.203
202303 0.258 301.836 0.277
202306 1.965 305.109 2.087
202309 3.075 307.789 3.237
202312 -0.228 306.746 -0.241
202403 19.965 312.332 20.714
202406 -0.711 314.175 -0.733
202409 -0.511 315.301 -0.525
202412 -2.150 315.605 -2.208
202503 12.261 319.799 12.424
202506 -19.755 322.561 -19.846
202509 -2.109 324.800 -2.104
202512 18.941 324.054 18.941

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ARS3.74 mean?
Instituto Rosenbusch (BUE:ROSE) has a Cyclically Adjusted FCF per Share of ARS3.74 as of Dec. 2025. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Instituto Rosenbusch and its competitors.
Is Instituto Rosenbusch's Cyclically Adjusted FCF per Share too high?
Instituto Rosenbusch's current Cyclically Adjusted FCF per Share is ARS3.74. Overall, Instituto Rosenbusch has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Instituto Rosenbusch's Cyclically Adjusted FCF per Share compare to ZTS and UTHR?
Instituto Rosenbusch's Cyclically Adjusted FCF per Share of ARS3.74 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Instituto Rosenbusch and its competitors. Instituto Rosenbusch's current Cyclically Adjusted FCF per Share is ARS3.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Instituto Rosenbusch stock overvalued right now?
Based on GuruFocus' analysis, Instituto Rosenbusch (BUE:ROSE) is currently considered Significantly Overvalued. The stock's GF Value™ is ARS62.32, compared to a current price of ARS156.00 — trading 150.3% above its estimated fair value. The current Cyclically Adjusted FCF per Share is ARS3.74. Instituto Rosenbusch's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Instituto Rosenbusch (BUE:ROSE), the current Cyclically Adjusted FCF per Share is ARS3.74 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Instituto Rosenbusch (BUE:ROSE) Overvalued in 2026?

Based on GuruFocus' analysis, Instituto Rosenbusch stock appears to be overvalued. The current stock price of ARS156.00 is trading 150.3% above its estimated GF Value™ of ARS62.32. GuruFocus considers Instituto Rosenbusch to be Significantly Overvalued.

Key valuation signals for BUE:ROSE:

  • Cyclically Adjusted FCF per Share: ARS3.74
  • GF Value™: ARS62.32 vs. price of ARS156.00 (150.3% above fair value)
  • GF Score™: 37/100 with 4 warning signs

No single metric tells the full story. See the BUE:ROSE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Instituto Rosenbusch Business Description

Address Hipolito Yrigoyen 1628, Buenos Aires, ARG, C1089AAF
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.
37GF Score

Get the complete analysis for BUE:ROSE

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS156.00
Price
ARS62.32
GF Value